Aug 13 (Reuters)-
D.Western Therapeutics Institute Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Jun 30, 2026 Jun 30, 2025 Dec 31, 2026
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 33 mln 173 mln 300 mln
(-80.9 pct) (-22.5 pct) (-22.6 pct)
Operating loss 312 mln loss 309 mln loss 780 mln
Recurring loss 322 mln loss 316 mln loss 800 mln
Net loss 323 mln loss 316 mln loss 800 mln
EPS loss 5.80 yen loss 7.08 yen loss 14.75 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - D.Western Therapeutics Institute Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4576.T